CryptoSlate
Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug
Enlivex pledged commercially reasonable efforts to hold the shareholder vote within 60 days, while the second $400 million remains optional.
Lees het volledige bericht op CryptoSlate
Opent in een nieuw tabblad. Via Cryptopage meten we de klik voor statistieken.
Partner
